×
Shuttle Pharmaceuticals Holdings Price to Free Cash Flow Ratio 2022-2024 | SHPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Shuttle Pharmaceuticals Holdings price to free cash flow ratio from 2022 to 2024. Price to free cash flow ratio can be defined as
View More
Shuttle Pharmaceuticals Holdings Price to Free Cash Flow Ratio 2022-2024 | SHPH
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Shuttle Pharmaceuticals Holdings price to free cash flow ratio from 2022 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Zoetis (ZTS)
$79.7B
Takeda Pharmaceutical (TAK)
$42.4B
Sandoz Group AG (SDZNY)
$19.3B
Merck (MKKGY)
$18.8B
Astellas Pharma (ALPMY)
$18.3B
United Therapeutics (UTHR)
$16.4B
Summit Therapeutics (SMMT)
$13.6B
Neurocrine Biosciences (NBIX)
$12.7B
Shionogi (SGIOY)
$11.8B
Catalent (CTLT)
$10.8B
Jazz Pharmaceuticals (JAZZ)
$7.6B
Madrigal Pharmaceuticals (MDGL)
$7.2B
Orion OYJ (ORINY)
$6.7B
Corcept Therapeutics (CORT)
$5.9B
Ionis Pharmaceuticals (IONS)
$5.4B
Crinetics Pharmaceuticals (CRNX)
$5.3B
PTC Therapeutics (PTCT)
$3.3B
Dyne Therapeutics (DYN)
$3B
AMNEAL PHARMACEUTICALS, INC (AMRX)
$2.6B
Catalyst Pharmaceuticals (CPRX)
$2.5B
Soleno Therapeutics (SLNO)
$2.4B
Arrowhead Pharmaceuticals (ARWR)
$2.3B
Centessa Pharmaceuticals (CNTA)
$2.1B
Evotec AG (EVO)
$1.9B
NewAmsterdam Pharma (NAMS)
$1.9B
Xencor (XNCR)
$1.7B
Recursion Pharmaceuticals (RXRX)
$1.6B
Harrow (HROW)
$1.6B
BioCryst Pharmaceuticals (BCRX)
$1.6B
Cassava Sciences (SAVA)
$1.5B